Determination of puerarin in rat plasma by rapid resolution liquid chromatography tandem mass spectrometry in positive ionization mode

被引:32
作者
Luo, Cheng-Feng [1 ]
Yuan, Mu [2 ]
Chen, Min-Sheng [1 ]
Liu, Shi-Ming [1 ]
Huang, Bi-Yun [2 ]
Liu, Xia-Wen [2 ]
Zhu, Liu [2 ]
机构
[1] Guangzhou Med Univ, Guangzhou Inst Cardiovasc Dis, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China
[2] Guangzhou Med Univ, Guangzhou, Guangdong, Peoples R China
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2011年 / 879卷 / 19期
基金
国家高技术研究发展计划(863计划);
关键词
Rapid resolution liquid chromatography; Mass spectrometry; Electrospray ionization; Puerarin; Pharmacokinetics; Rats; BIOAVAILABILITY; METABOLITES; FLAVONOIDS; ISOFLAVONE; RABBITS; TABLETS; SERUM; HPLC;
D O I
10.1016/j.jchromb.2011.03.035
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
A highly sensitive and specific method of rapid resolution liquid chromatography tandem mass spectrometry (RRLC-MS/MS) in positive ionization mode has been developed and validated for pharmacokinetic study of puerarin in rat plasma. Chromatography was carried out on a Zorbax XDB C18 reversed-phase column using a mobile phase comprising a mixture of methanol and 0.05% acetic acid in water (35:65, v/v) with a flow rate of 0.3 mL/min from 0 min to 5.4 min and then 0.6 mL/min from 5.41 min to 12 min. The mass spectrometer operated in ESI positive ionization mode. Multiple reaction monitoring (MRM) was used to measure puerarin and tectoridin (internal standard). The method was sensitive with a detection limit of 0.33 ng/mL. A good linear response was observed over a range of 10-2000 ng/mL in rat plasma. The inter- and intra-day precision ranged from 2.97% to 7.52% and accuracy from 93.70% to 101.60%. This validated method was applied successfully to a pharmacokinetic study in rat plasma after intravenous administration of puerarin. The main pharmacokinetic parameters were as follows: AUC(0-1) 45.37 +/- 13.19 (mg h/L), AUC(0-infinity) 47.03 +/- 14.78 (mg h/L), MRT 1.03 +/- 0.46 (h), T(1/2) 1.31 +/- 0.31 (h), V(ss) 0.09 +/- 0.02 (L), V(z) 0.17 +/- 0.04 (L), Cl 0.10 +/- 0.04 (L/h). (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:1497 / 1501
页数:5
相关论文
共 22 条
[1]
Study on the bioavailability of puerarin from Pueraria lobata isoflavone self-microemulsifying drug-delivery systems and tablets in rabbits by liquid chromatography-maas spectrometry [J].
Cui, SM ;
Zhao, CS ;
Tang, X ;
Chen, DW ;
He, ZG .
BIOMEDICAL CHROMATOGRAPHY, 2005, 19 (05) :375-378
[2]
Guo D.Y., 2008, J SHAANXI COLL TRADI, V31, P52
[3]
Puerarin and conjugate bases as radical scavengers and antioxidants:: Molecular mechanism and synergism with β-carotene [J].
Han, Rui-Min ;
Tian, Yu-Xi ;
Becker, Eleonora Miquel ;
Andersen, Mogens L. ;
Zhang, Jian-Ping ;
Skibsted, Leif H. .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2007, 55 (06) :2384-2391
[4]
Determination of puerarin by capillary electrophoresis with chemiluminescence detection [J].
Han, Suqin .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2009, 877 (14-15) :1591-1594
[5]
HOU ZS, 2008, ADRJ, V10, P1
[6]
Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats [J].
Hsu, FL ;
Liu, IM ;
Kuo, DH ;
Chen, WC ;
Su, HC ;
Cheng, JT .
JOURNAL OF NATURAL PRODUCTS, 2003, 66 (06) :788-792
[7]
JIN XL, 1992, ACTA PHARM SINIC, V13, P284
[8]
Pharmacokinetic, tissue distribution, and excretion of puerarin and puerarin-phospholipid complex in rats [J].
Li, Y ;
Pan, WS ;
Chen, SL ;
Xu, HX ;
Yang, DJ ;
Chan, ASC .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2006, 32 (04) :413-422
[9]
LIU R, 2007, J CHIN MAT MED, V2, P2058
[10]
Determination of puerarin in human plasma by high performance liquid chromatography [J].
Ma, ZZ ;
Wu, QL ;
Lee, DYW ;
Tracy, M ;
Lukas, SE .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 823 (02) :108-114